Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

MedWellAI (MWAI) EBITDA Margin (2016 - 2025)

MedWellAI (MWAI) has disclosed EBITDA Margin for 11 consecutive years, with 48.41% as the latest value for Q4 2025.

  • Quarterly EBITDA Margin rose 16484.0% to 48.41% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 32.02% through Dec 2025, down 10951.0% year-over-year, with the annual reading at 128.07% for FY2025, N/A changed from the prior year.
  • EBITDA Margin for Q4 2025 was 48.41% at MedWellAI, up from 330.64% in the prior quarter.
  • The five-year high for EBITDA Margin was 1331.92% in Q2 2021, with the low at 51062.02% in Q3 2024.
  • Average EBITDA Margin over 5 years is 2679.31%, with a median of 66.89% recorded in 2022.
  • The sharpest move saw EBITDA Margin plummeted -5020685bps in 2024, then surged 5073138bps in 2025.
  • Over 5 years, EBITDA Margin stood at 13.03% in 2021, then tumbled by -1166bps to 164.91% in 2022, then soared by 88bps to 19.42% in 2023, then tumbled by -998bps to 213.25% in 2024, then soared by 77bps to 48.41% in 2025.
  • According to Business Quant data, EBITDA Margin over the past three periods came in at 48.41%, 330.64%, and 612.1% for Q4 2025, Q3 2025, and Q2 2025 respectively.